The immune system and memory consolidation: A role for the cytokine IL-1β

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 1, 2001, Pages 29-41

  Rachal Pugh, C ^a   Fleshner, Monika ^a   Watkins, Linda R ^a   Maier, Steven F ^a   Rudy, Jerry W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

AIDS Dementia; Alzheimer's Disease; Fear Conditioning; gp120; Interleukin 1 beta; Lipopolysaccharide; Memory Consolidation; Stress

Indexed keywords

INTERLEUKIN 1BETA;

AIDS RELATED COMPLEX; ALZHEIMER DISEASE; AMNESIA; HIPPOCAMPUS; HUMAN; IMMUNE SYSTEM; LEARNING; MEMORY; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIAL ISOLATION; STRESS;

EID: 0035143435     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(00)00048-8     Document Type: Article

References (112)

1. Cytokines for psychologists: implications of bi-directional immune to brain communication for understanding behavior, mood, and cognition
2. Behavioral effects of cytokines
3. Interleukin-1 signaling occurs exclusively via the type I receptor
4. Pharmacology of interleukin-1 actions in brain
5. Gene expression and function of interleukin-1, interleukin-6, and tumor necrosis factor in brain
6. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning
7. Role of interleukin-1β in impairment of contextual fear conditioning caused by social isolation
8. Visualization and characterization of interleukin-1 receptors in brain
9. Interleukin-1 receptors in mouse brain: characterization and neuronal localization
10. Receptors for interleukin 1 (α and β) in mouse brain mapping and neuronal localization in hippocampus
11. Interleukin-1 receptors in the brain and endocrine tissue
12. Brain interleukin-1 gene expression induced by peripheral lipopolysaccharide administration
13. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice
14. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS
15. Dynamic regulation of the proinflammatory cytokine interleukin-1 beta: molecular biology for non-molecular biologists
16. Exposure to acute stress induces brain interleukin-1 protein in the rat
17. What is the biological significance of an age-related increase in IL-1β in hippocampus?
18. Molecular mechanisms of synaptic plasticity and memory
19. Interleukin-1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus
20. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
21. Actions of the proinflammatory cytokine IL-1β on central synaptic transmission
22. Interleukin-1 beta (IL-1β) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro
23. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans
24. Cognitive neuroscience and the study of memory
25. Mechanisms of memory
26. The hippocampus and space revisited
27. The hippocampus and contextual retrieval of information from memory: a theory
28. Configural association theory: the role of the hippocampal formation in learning, memory, and amnesia
29. Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA
30. Emotion
31. The amygdala and fear conditioning: has the nut been cracked?
32. The neuroanatomical and neurochemical basis of conditioned fear
33. Modality-specific retrograde amnesia of fear
34. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning
35. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning
36. Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells
37. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat
38. Factors governing one trial contextual conditioning
39. A selective role for corticosterone in contextual-fear conditioning
40. Contextual fear conditioning, conjunctive representations, pattern completion, and the hippocampus
41. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain
42. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats
43. Human Immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin-1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses
44. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments
45. α-Melanocyte stimulating hormone peptides in host responses
46. Immobilization stress induces interleukin-β mRNA in the rat hypothalamus
47. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat
48. Post-conditioning isolation disrupts contextual fear conditioning: an experimental analysis
49. Isolation reduces contextual but not auditory-cue fear conditioning: a role for endogenous opioids
50. Interleukin-1 beta, but not interleukin-6 impairs spatial navigation learning
51. Legionella pneumophila-induced visual learning impairment reversed by anti-interleukin-1 beta
52. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat
53. Resistance to extinction after schedules of partial delay or partial reinforcement in rats with hippocampal lesions
54. The effects of delaying reward on choice preference in rats with hippocampal or selective septal lesions
55. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist AP5
56. Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5
57. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
58. Sex differences in hippocampal long-term potentiation (LTP) and Pavlovian fear conditioning in rats: positive correlation between LTP and contextual learning
59. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon1 subunit
60. A neuromodulatory role of interleukin-1β in the hippocampus
61. Adenosine: a mediator of interleukin-1β induced hippocampal synaptic inhibition
62. Interleukin-1 augments GABAA receptor function in brain
63. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1β
64. Role of cytokines in infection-induced stress
65. Cytokine-specific central monoamine alterations induced by interleukin-1, -2, and -6
66. Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity
67. Chronic stress impairs rat spatial memory on the Y-maze, and this effect is blocked by tianeptine pretreatment
68. Prevention of stress-induced morphological and cognitive consequences
69. Repeated stress causes reversible impairments of spatial memory performance
70. A long-term stress exposure impairs maze learning performance in rats
71. Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function
72. Behavioral stress impairs long-term potentiation in rodent hippocampus
73. Psychological stress repeatedly blocks hippocampal primed burst potentiation in behaving rats
74. Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation
75. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
76. Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature
77. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study
78. Sr Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory
79. Membrane arachidonic acid concentration correlates with age and induction of long-term potentiation in the dentate gyrus in the rat
80. The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane arachidonic acid concentration is reversed
81. Age-related changes in synaptic plasticity in rat hippocampus
82. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
83. Glial cytokines in Alzheimer's disease: review and pathogenic implications
84. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution
85. Brain interleukin-1β in Alzheimer's disease and vascular dementia
86. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors
87. Cerbrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders
88. Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients
89. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease
90. Interleukin-1 stimulates the beta-amyloid precursor protein promoter
91. Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: modulation by interleukin-1
92. Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells
93. Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor
94. Neuronal death, proinflammatory cytokines and amyloid precursor protein: studies on staggerer mutant mice
95. Cytokines in dementia of the Alzheimer's type (DAT) relevance to research and treatment
96. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
97. β-amyloid fragment potentiates IL-6 and TNFα secretion by LPS in astrocytes but not in microglia
98. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression
99. Head injury as a risk factor in Alzheimer's disease
100. The association between head trauma and Alzheimer's disease
101. Clinical trial of indomethacin in Alzheimer's disease
102. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Initial results of a co-twin study
103. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?
104. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease
105. dementia complex: I. Clinical features
106. Central nervous system dysfunction in Acquired Immunodeficiency Syndrome
107. The AIDS dementia complex
108. Cytokine expression in the brain during the acquired Immunodeficiency syndrome
109. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide
110. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human Immunodeficiency virus type 1
111. TNF-alpha and IFN-gamma mediated signal transduction pathways: effects on glial cell gene expression and function